New care model for frail older adults after hospital discharge

AdvantAGE: Implementation and Evaluation of an Interprofessional Transitional Care Model for Frail Older Adults at the University Department of Geriatric Medicine FELIX PLATTER

Not applicable Interventional University Department of Geriatric Medicine FELIX PLATTER · NCT06190288

This study is testing a new support program for frail older adults after they leave the hospital to see if it helps them stay healthy and avoid going back to the hospital within 90 days.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment250 (estimated)
Ages65 Years and up
SexAll
SponsorUniversity Department of Geriatric Medicine FELIX PLATTER Academic / other
Locations1 site (Basel)
Trial IDNCT06190288 on ClinicalTrials.gov

What this trial studies

This clinical trial at the University Department of Geriatric Medicine FELIX Platter in Basel, Switzerland, evaluates a transitional care model designed to support frail older adults post-hospital discharge. The AdvantAGE study aims to determine if this model can reduce hospital readmissions within 90 days and assess its implementation effectiveness. Participants will receive assistance from advanced practice nurses for up to 90 days, focusing on care coordination, medication management, and health condition self-management, along with discussions on advanced care planning.

Who should consider this trial

Good fit: Ideal candidates are frail older adults aged 65 and above, residing in Basel-Stadt, who are at high risk of deterioration and scheduled for discharge to their home.

Not a fit: Patients residing in nursing homes or those without informal caregivers may not benefit from this study.

Why it matters

Potential benefit: If successful, this model could significantly reduce hospital readmissions and improve the quality of life for frail older adults.

How similar studies have performed: Other studies have shown success with transitional care models for older adults, indicating potential for positive outcomes in this approach.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Currently admitted to the acute or rehabilitation ward of University Department of Geriatric Medicine
* Reside in Basel-Stadt
* Possess the ability to speak and comprehend the German language
* Scheduled to be discharged to their home
* 65 years or older
* Identified by a clinician as having a high risk of deterioration due to frailty

Additionally, participants must meet at least one of the following criteria:

* diagnosed with a complex chronic disease requiring support in self-management and disease management, or
* facing socially challenging situations such as living alone without a supportive network or lacking a GP, or
* admitted for an acute illness with a brief hospital stay (e.g., infection, cardiac decompensation) and need support in self- and disease management, and continuity of the therapy plan, including close monitoring.

Exclusion Criteria:

* residing in a nursing home or being newly admitted to one
* lacking informal caregivers and exhibiting severe cognitive impairment (MMS ≤23)
* scoring \<50 on the motoric domain of the Functional Independence Measure (FIM)
* having a psychiatric disorder that significantly impacts their ability to manage daily life at time of the discharge

Where this trial is running

Basel

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Transitional CareMultimorbidityGeriatric CareTransitional Care, Frailty, Rehospitalisation, Geratric Care
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.